Oncolytics Biotech (ONCY) Receivables - Net (2009 - 2026)
Oncolytics Biotech (ONCY) posted quarterly Receivables - Net of $527000.0 for Q4 2025, down 100.0% quarter-over-quarter from $33.1 billion in Q3 2017.
Oncolytics Biotech (ONCY) Receivables - Net (2009 - 2026) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Receivables - Net for 10 consecutive years, with $527000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Receivables - Net changed N/A year-over-year to $527000.0; the TTM figure through Dec 2025 stood at $527000.0 (changed N/A YoY), while the FY2025 annual figure was $527000.0, changed N/A from the prior year.
- Receivables - Net slipped to $527000.0 in Q4 2025 per ONCY's latest filing, from $33.1 billion in the prior quarter.
- Across five years, Receivables - Net topped out at $527000.0 in Q4 2025 and bottomed at $527000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - |
| 10 | Oncolytics Biotech | 97.90 Mn | 97.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Jun 30, 2026 | 1.18 Mn |
| Dec 31, 2025 | 527,000.00 |
| Dec 31, 2025 | 527,000.00 |
| Sep 30, 2017 | 33.13 Bn |
| Sep 30, 2017 | 33.13 Bn |
| Jun 30, 2017 | 62,109.00 |
| Jun 30, 2017 | 62,109.00 |
| Mar 31, 2017 | 36,484.00 |
| Mar 31, 2017 | 36,484.00 |
| Dec 31, 2016 | 54.41 Bn |
| Dec 31, 2016 | 54.41 Bn |
| Sep 30, 2016 | 44.99 Bn |
| Sep 30, 2016 | 44.99 Bn |
| Jun 30, 2016 | 285,426.00 |
| Jun 30, 2016 | 285,426.00 |
| Mar 31, 2016 | 59.65 Bn |
| Mar 31, 2016 | 59.65 Bn |
| Dec 31, 2015 | 340,059.00 |
| Dec 31, 2015 | 340,059.00 |